Tourtellotte Appointed Associate Director of Medical Scientist Training Program
 |
| Warren G. Tourtellotte, MD, PhD, associate professor of pathology, neurology and neuroscience, was recently appointed to associate director of the Medical Scientist Training Program. |
Warren G. Tourtellotte, MD, PhD, associate professor of pathology, neurology and neuroscience at Northwestern University Feinberg School of Medicine, was recently appointed to associate director of the medical school’s Medical Scientist Training Program (MSTP) — a premier biomedical research program that has trained more than 220 MD/PhD physician-scientists for careers in academic medicine, government and the biotechnology-pharmaceutical industry.
Tourtellotte came to Northwestern in 2000 and has served in other leadership roles at the medical school, including director of the Northwestern Transgenic and Targeted Mutagenesis Laboratory and director of the Northwestern Research Histology and Phenotyping Laboratory. Tourtellotte has also been active in the MSTP, having served as director of admissions, class advisor to current second-year students, and research advisor to two MD/PhD graduates as well as a current student.
In addition to his NIH-funded research program, Tourtellotte participates in the practice of anatomic pathology and neuropathology at Northwestern Memorial Hospital. The Tourtellotte Lab focuses on transcriptional regulation in central and peripheral nervous system development, and his research has been published in leading journals such as Science, Nature Genetics, Journal of Cell Biology and Development.
David M. Engman, MD, PhD, Sandra Lee, PhD, and Hossein Ardehali, MD, PhD, will continue as MSTP director, administrative director, and director of admissions, respectively.
“Over the past fifteen years, the MSTP has flourished under the direction of Dr. Engman and is among the top programs in the country,” says J. Larry Jameson, MD, PhD, vice president for medical affairs and Lewis Landsberg Dean of the medical school. “I am confident that the addition of Dr. Tourtellotte will further strengthen the MSTP, allowing the program to thrive at a time when the physician-scientist will play an increasingly important role in basic biomedical discovery and in translating these discoveries into new diagnostics and therapeutics for human disease.”
